跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
赞可达 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ceritinib Capsules
Approved
化学药品
Ceritinib Capsules
NOVARTIS EUROPHARM LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Nov 16, 2022
Approval ID
b5bcfd9b322509c8
Company
NOVARTIS EUROPHARM LIMITED
Type
化学药品
Approval Details
Approval Id
b5bcfd9b322509c8
Approval Number
国药准字HJ20180025
Generic Name
塞瑞替尼胶囊
Generic Name En
Ceritinib Capsules
Trade Name
赞可达
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
150mg
Reg Date
2022-11-16
Expired Date
2027-11-15
Company Name
NOVARTIS EUROPHARM LIMITED
Production Company Name
Novartis Pharma Stein AG
Company Detail Path
/organization/novartis-europharm-limited
Production Company Detail Path
/organization/novartis-pharma-stein-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 16, 2022
Approval ID
b5bcfd9b322509c8
Type
化学药品
Back to NMPA Approvals